Guardian Pharmacy Services (NYSE:GRDN) Trading Up 4.6% – Here’s What Happened

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) rose 4.6% during mid-day trading on Monday . The stock traded as high as $22.43 and last traded at $22.39. Approximately 37,424 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 188,664 shares. The stock had previously closed at $21.41.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Stephens assumed coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 target price for the company. Truist Financial increased their price objective on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Finally, Raymond James assumed coverage on Guardian Pharmacy Services in a research report on Monday, October 21st. They issued an “outperform” rating and a $21.00 target price for the company.

Guardian Pharmacy Services Trading Down 6.4 %

The business has a 50-day moving average of $21.42.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. Equities analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of the stock in a transaction dated Friday, September 27th. The shares were purchased at an average cost of $14.00 per share, with a total value of $499,996.00. Following the transaction, the director now directly owns 35,714 shares in the company, valued at approximately $499,996. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Steven D. Cosler bought 7,000 shares of Guardian Pharmacy Services stock in a transaction that occurred on Tuesday, November 19th. The stock was purchased at an average cost of $21.22 per share, with a total value of $148,540.00. Following the completion of the acquisition, the director now directly owns 17,713 shares in the company, valued at $375,869.86. This represents a 65.34 % increase in their position. The disclosure for this purchase can be found here.

Institutional Trading of Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently modified their holdings of GRDN. Wellington Management Group LLP bought a new position in Guardian Pharmacy Services in the 3rd quarter worth $8,400,000. Franklin Resources Inc. purchased a new position in shares of Guardian Pharmacy Services in the third quarter valued at about $8,575,000. Foundry Partners LLC bought a new position in shares of Guardian Pharmacy Services in the third quarter worth about $1,680,000. Allspring Global Investments Holdings LLC bought a new position in shares of Guardian Pharmacy Services in the third quarter worth about $5,460,000. Finally, Maven Securities LTD purchased a new stake in shares of Guardian Pharmacy Services during the third quarter worth about $3,033,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.